Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1988
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: This study is classified as reliable with restrictions because there was no GLP statement provided, and limited data on methods were reported, but the study seemed to be well-conducted.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1988

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
This study examined the effect of inhalation of n-hexane vapors to fetal development. Groups of 35 pregnant and 10 virgin female mice were exposed to concentrations of 0, 200, 1000, or 5000 ppm of test substance vapors for 20 hrs/day, daily, during gestational days 6 -17. During exposure, females were weighed regularly. At the end of the exposure period, the females were sacrificed, and the uterine contents were examined for parameters including number of live fetuses, number of implantations, and number of resorptions. Fetuses were also examined for malformations.
GLP compliance:
no
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
N-hexane
EC Number:
203-777-6
EC Name:
N-hexane
Cas Number:
110-54-3
Molecular formula:
C6H14
IUPAC Name:
hexane
Details on test material:
- Name of test material (as cited in study report): n-hexane
- Analytical purity: 99.2%
- Lot/batch No.: H-222
- Storage condition of test material: 65 degree F, stored under a blanket of nitrogen

Test animals

Species:
mouse
Strain:
CD-1
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River, Raleigh NC
- Weight at study initiation: 28.7-31.5 g
- Housing: cages
- Diet (e.g. ad libitum): NIH-07 diet, ad libitum
- Water (e.g. ad libitum): ad libitum



ENVIRONMENTAL CONDITIONS
- Temperature (°C): 73 +/- 3 degrees F
- Humidity (%): 50 +/- 15 %
- Air changes (per hr): approx. 15
- Photoperiod (hrs dark / hrs light): 12 hrs light/12 hrs dark

Administration / exposure

Route of administration:
inhalation: vapour
Type of inhalation exposure (if applicable):
whole body
Details on exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Battelle-designed chambers, 2.3 m3 stainless steel chambers
- Method of holding animals in test chamber: cages
- Method of conditioning air: Hexane in a 19 l stainless steel reservoir is pumped into delivery tubes to vaporizers at the fresh air inlet to the exposure chambers. The vaporizers are heated to aid in evaporation. Micrometering pumps are used to adjust the concentration.
- System of generating particulates/aerosols:
- Temperature, humidity in air chamber: 73 +/- 3 degree F, 50 +/- 15%
- Air change rate: approx. 15 changes per hour
- Treatment of exhaust air: building exhaust


TEST ATMOSPHERE
- Brief description of analytical method used: Atmosphere was tested using a on-line GC with automatic 8-port sampling valve.
- Samples taken from breathing zone: yes
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Atmosphere was tested using a on-line GC with automatic 8-port sampling valve.
Details on mating procedure:
- Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: 1 male to 1-2 females
- Length of cohabitation: up to five nights
- Proof of pregnancy: vaginal plug referred to as day 0 of pregnancy
Duration of treatment / exposure:
20 hrs/day
Frequency of treatment:
daily
Duration of test:
gestation days 6-17
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 200, 1000, 5000 ppm
Basis:
nominal conc.
No. of animals per sex per dose:
35 pregnant females, 10 virgins per dose
Control animals:
yes, sham-exposed

Examinations

Maternal examinations:
BODY WEIGHT: Yes
- Time schedule for examinations: plug positive females - days 0, 6, 9, 12, and 18
virgin females - 12 day prior to exosure, days 1, 4 and 7, before sacrifice


POST-MORTEM EXAMINATIONS: Yes / No / No data
- Sacrifice on gestation day 20
- Organs examined: nongravid uteri

Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
Fetal examinations:
- External examinations: Yes: all per litter
- Soft tissue examinations: Yes: all per litter
- Skeletal examinations: Yes: half per litter
- Head examinations: Yes: half per litter
Statistics:
SAS statistical software, Duncan's multiple range test
Mean body weigths: SAS General Linear Models Procedure with analysis of variance
Dose response: orthogonal trend test

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects:yes

Details on maternal toxic effects:
Mean weight gain for pregnant females in the 5000 ppm group was significantly reduced compared to controls. There was also a significant reduction in gravid uterine weight in the 200 and 5000 ppm groups. A significant reduction in uterine weight to extra-gestational weight gain was seen in the 5000 ppm group as well. Number of implantations per litter was also reduced in the 5000 ppm group, and also the number of live implants per litter. An increase in intrauterine death was significantly greater only in the 200 ppm group. The incidence of late resorptions was significantly increased in the 5000 ppm group.

Effect levels (maternal animals)

open allclose all
Key result
Dose descriptor:
NOAEC
Effect level:
1 000 ppm
Basis for effect level:
other: maternal toxicity
Dose descriptor:
LOAEC
Effect level:
5 000 ppm
Basis for effect level:
other: maternal toxicity
Key result
Dose descriptor:
LOAEC
Effect level:
200 ppm
Basis for effect level:
other: developmental toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:yes

Details on embryotoxic / teratogenic effects:
Fetal weights of females in the 5000 ppm group were significantly reduced. The only significant increase in malformations as compared to controls, was an exencephalic fetus in the 5000 ppm group, however, as this was only seen in one fetus, and this malformation was also present in the control group, it is not considered treatment related. Rather it is an anomalous result due to the low background incidence of this malformation.

Effect levels (fetuses)

Key result
Dose descriptor:
LOAEC
Effect level:
200 ppm
Basis for effect level:
other: developmental toxicity

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

Significant results of mouse developmental toxicity study

Concentration

0 ppm

200 ppm

1000 ppm

5000 ppm

Mean body weight – gestational day 18 (g)

57.0 ± 5.0

54.8 ± 4.0

55.7 ± 4.9

53.7 ± 4.6

Uterine mean weight (g)

21.4 ± 3.8

19.2 ± 3.4

20.2 ± 3.5

17.8 ± 3.9

Live fetuses/litter

12.0 ± 2.6

10.6 ± 2.2

11.4 ± 2.4

10.2 ± 2.7

Resorptions/litter

0.6 ± 0.7

1.6 ± 1.7

0.8 ± 0.9

1.1 ± 1.2

Late resorptions/litter

0.0 ± 0.2

0.4 ± 0.9

0.4 ± 0.6

0.5 ± 0.8

% live fetuses/litter

95.5 ± 5.6

87.2 ± 12.2

93.5 ± 7.2

89.7 ± 12.4

% resorptions/litter

4.5 ± 5.6

12.8 ± 12.2

6.5 ± 7.2

10.3 ± 12.4

% late resorptions/litter

0.3 ± 1.3

3.4 ± 6.6

2.9 ± 4.6

4.5 ± 6.5

Female fetal weight (g)

1.39 ± 0.10

1.37 ± 0.10

1.35 ± 0.10

1.31 ± 0.11

% exencephaly/litter affected

0 ± 0

0 ± 0

0 ± 0

0.5 ± 2.5

Applicant's summary and conclusion

Conclusions:
The maternal NOAEC was 1000 ppm, and the maternal LOAEC was 5000 ppm based on reduced body weight. The developmental LOAEC was 200 ppm (704 mg/m3) based on increased resorptions and reduced uterine weight. There was no NOAEC for developmental toxicity.
Executive summary:

This study examined the effect of inhalation of n-hexane vapors to fetal development. Groups of 35 pregnant and 10 virgin female mice were exposed to concentrations of 0, 200, 1000, or 5000 ppm of test substance vapors for 20 hrs/day, daily, during gestational days 6 -17. During exposure, females were weighed regularly. At the end of the exposure period, the females were sacrificed, and the uterine contents were examined for parameters including number of live fetuses, number of implantations, and number of resorptions. Fetuses were also examined for malformations. Body weight was significantly reduced in 5000 ppm exposure females. There was significant reduction in gravid uterine weight in the 200 ppm group, there was also an increase in intrauterine death in this group. Fetal weights were also reduced in the 5000 ppm group. No biologically significant increase in malformations was found. The NOAEC for maternal toxicity is 1000 ppm, and the LOAEC is 5000 ppm based on reduced body weight. There was no NOAEC found for developmental toxicity, and the LOAEC is 200 ppm (704 mg/m3) based on reduced fetal weight gain.